The resource provides integrated RNA-seq, ATAC-seq, aCGH, single-drug and combination sensitivity data from 38 T-cell lymphoma cell lines across major clinical T-cell lymphoma subtypes.
This research represents a collaborative effort across multiple institutions in cancer research and precision medicine, bringing together expertise from universities and research centers across Europe and North America.